Reuters logo
BRIEF-Diplomat dispensing Revlimid for multiple myeloma maintenance therapy following autologous hematopoietic stem cell transplant (auto-HSCT)
March 2, 2017 / 2:03 PM / 7 months ago

BRIEF-Diplomat dispensing Revlimid for multiple myeloma maintenance therapy following autologous hematopoietic stem cell transplant (auto-HSCT)

March 2 (Reuters) - Diplomat Pharmacy Inc

* Diplomat dispensing Revlimid for multiple myeloma maintenance therapy following autologous hematopoietic stem cell transplant (auto-HSCT) Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below